Bajaj Healthcare launches drug to treat black fungus infection in COVID-19 patients

The company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat (India), to manufacture and market Posaconazole API as approved medication for treating Mucormycosis in India, Bajaj Healthcare said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fM75RI
via IFTTT